FDA Inspection 554921 — Apotex, Inc.

Apotex, Inc. — FEI 3002808376

The FDA completed an inspection of Apotex, Inc. on December 19, 2008 in Etobicoke. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 19, 2008
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Etobicoke (Canada)